Will cooperation between Healthcare firms continue as a trend, increasing healthcare M&A?

Will cooperation between Healthcare firms continue as a trend, increasing healthcare M&A?

Siemens Healthineers (SHL.DE) announced that it would acquire Varian Medical Systems (VAR) on the 2nd of August 2020 for USD 16.4bn. Siemens will purchase all of Varian's shares for $177.50/share in cash; a 24% premium. The deal will be financed...

Continue reading →

Horseshoe crab blood is key to making a Covid-19 vaccine – but the ecosystem may suffer

Horseshoe crab blood is key to making a Covid-19 vaccine – but the ecosystem may suffer

In 2016 a synthetic alternative (rFC) to horseshoe crab blood, used in bacterial infection detection for injectable procedures, was licensed. And yet horseshoe crabs are both threatened with extinction and in line for preservation due to Covid-19 and its...

Continue reading →

How will the rise of biosimilars impact biologics

How will the rise of biosimilars impact biologics

● Once patents expire for biologic medicines, a market opportunity opens up for biosimilars, a cheaper alternative. Biosimilars were mainly brought in to thwart the monopoly power of biologics in the pharmaceutical industry. ● Biosimilars are expected to increase at...

Continue reading →